Jane Street’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.65M Buy
191,400
+165,400
+636% +$1.8M ﹤0.01% 5530
2026
Q2
$325K Sell
26,000
-14,200
-35% -$190K ﹤0.01% 9029
2026
Q1
$599K Sell
40,200
-3,000
-7% -$66.8K ﹤0.01% 7624
2025
Q4
$1.08M Buy
+43,200
New +$769K ﹤0.01% 5964

Other funds holding OLMA

Jane Street's OLMA Position: Q2 2025 in Review

Jane Street sold out of Olema Oncology (OLMA) in Q2 2025, closing a stake of 138,552 shares — an estimated $521K sold.

Jane Street first reported a position in OLMA in Q4 2021 and held it in 10 quarters. The position peaked at $570K in Q2 2024. 122 funds tracked by Wall St. Rank hold OLMA as of Q2 2025.

  • Jane Street reported no remaining Olema Oncology position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 138,552 Olema Oncology shares in Q2 2025, an estimated $521K.
  • Jane Street first reported a position in Olema Oncology in Q4 2021 and held it in 10 quarters.
  • Jane Street's Olema Oncology position peaked at $570K in Q2 2024.
  • 122 funds tracked by Wall St. Rank held Olema Oncology as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.